Effects on diurnal variations in blood pressure and cardiac hypertrophy of two types of long-acting nifedipine tablets in patients with essential hypertension - Comparison between nifedipine controlled release tablet: Once daily and nifedipine retard tablet (b.i.d.)

Japanese Pharmacology and Therapeutics

Volumn 29, Issue 10, 2001, Pages 767-776

  Kobayashi, Kazuo ^a   Okada, Yasuhiro ^a   Kamimura, Seiichiro ^a   Iida, Takeshi ^a   Manako, Kazuko ^a  

^a FUKUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Cardiac hypertrophy; Diurnal variations in blood pressure; Essential hypertension; Nifedipine

Indexed keywords

ADALAT CR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NIFEDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DRUG TOLERABILITY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LONG TERM CARE; MALE; PULSE RATE;

EID: 0035724018     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension
2. Prognostic value of 24 hour blood pressure variability
3. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
4. Nifedipine: Dose-related increase in mortality in patients with coronary heart desease
5. The risk of myocardial infarction associated with antihypertensive drug therapy
6. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding
7. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
8. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of hypertension optimal treatment (HOT) randomized trial
9. Morbidity and mortarity in patients randomized to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)